Name :
KEAP1 antibody
Documents :
DataSheet Material Safety Data Sheets (MSDS)
Description :
KEAP1 Mouse Monoclonal antibody. Positive WB detected in HeLa cells, Jurkat cells. Positive IHC detected in human pancreas cancer tissue, human endometrial cancer tissue, human kidney tissue, human skeletal muscle tissue. Observed molecular weight by Western-blot: 68+66 kDa
Tested applications :
ELISA, IHC, WB
Species reactivity :
Human, Rat; other species not tested.
Alternative names :
Cytosolic inhibitor of Nrf2 antibody; INrf2 antibody; KEAP1 antibody; Kelch like protein 19 antibody; KIAA0132 antibody; KLHL19 antibody
Immunogen :
Human KEAP1 Recombinant protein (GST tag)
Isotype :
IgA
Preparation :
This antibody was obtained by immunization of KEAP1 recombinant protein (Accession Number: XM_011528452). Purification method: Caprylic acid/ammonium sulfate precipitation.
Clonality :
Monoclonal
Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
Storage instructions :
Store at -20℃. DO NOT ALIQUOT
Applications :
Recommended Dilution: WB: 1:200-1:2000IHC: 1:20-1:200
Background :
KEAP1, also named as INRF2, KIAA0132 and KLHL19, is part of a multiprotein complex that contains the CUL3-Roc1 ubiquitin ligase, which can ubiquitinate the N-terminal domain of NRF2. Two molecules of KEAP1 bind to two distinct sites in the N-terminal region of NRF2, the ETGE and DLG sites, which affect the KEAP1-NRF2 interaction and/or its physiological consequences. KEAP1 retains NFE2L2/NRF2 in the cytosol. It functions as substrate adapter protein for the E3 ubiquitin ligase complex formed by CUL3 and RBX1. It also retains BPTF in the cytosol. This antibody is a mouse monoclonal antibody raised against residues near the C terminus of human KEAP1. Read more about this antibody on the blog:http://blog.ptglab.com/index.php/nsclc-research-anti-keap1-antibody-helps-uncover-targets-biomarker-potential/
References :
Soares MA, Cohen OD, Low YC. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche. Diabetes. 65(3):633-46. 2016. Chandiramani N, Wang X, Margeta M. Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line. PloS one. 6(1):e14485. 2011. Huang CF, Zhang L, Ma SR. Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma. PloS one. 8(12):e83479. 2013. Lee DF, Kuo HP, Liu M. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Molecular cell. 36(1):131-40. 2009. Zhao F, Li K, Zhao L. Effect of Nrf2 on rat ovarian tissues against atrazine-induced anti-oxidative response. International journal of clinical and experimental pathology. 7(6):2780-9. 2014. Choi CY, Kim JY, Wee SY. Expression of nuclear factor erythroid 2 protein in malignant cutaneous tumors. Archives of plastic surgery. 41(6):654-60. 2014. Lee YJ, Kwon SB, An JM. Increased protein oxidation and decreased expression of nuclear factor E2-related factor 2 protein in skin tissue of patients with diabetes. Clinical and experimental dermatology. 40(2):192-200. 2015. Jimenez-Blasco D, Santofimia-Castaño P, Gonzalez A, Almeida A, Bolaños JP. Astrocyte NMDA receptors’ activity sustains neuronal survival through a Cdk5-Nrf2 pathway. Cell death and differentiation. 22(11):1877-89. 2015.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Lutikizumab
p27 KIP 1 Antibody
HSF1 Antibody (YA896): HSF1 Antibody (YA896) is an unconjugated, approximately 57-80 kDa, rabbit-derived, anti-HSF1 (YA896) monoclonal antibody. HSF1 Antibody (YA896) can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human background without labeling.
